Corvus Pharmaceuticals, Inc.CRVSNASDAQ
Loading
Pre-tax earnings
Latest
$-15.28M
↑ 60% vs avg
Percentile
P82
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-38.08M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-15.28M | +75.5% |
| 2024 | $-62.29M | -130.5% |
| 2023 | $-27.03M | +34.6% |
| 2022 | $-41.31M | +4.5% |
| 2021 | $-43.24M | -621.3% |
| 2020 | $-6.00M | +87.2% |
| 2019 | $-46.67M | +0.6% |
| 2018 | $-46.94M | +15.7% |
| 2017 | $-55.66M | -53.0% |
| 2016 | $-36.38M | - |